EUVIMEDEUVIMED entdecken
Crossref

Angiotensin II type 2 receptor agonist attenuates LPS-induced acute lung injury through modulating THP-1-derived macrophage reprogramming

Liangzhi Chen, Ping Gong, Yue Su, Linlin Meng, Muyun Wang, Wei Gao, Qinghua Liu

Naunyn-Schmiedeberg's Archives of Pharmacology · 2024

DOI: 10.1007/s00210-023-02589-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2024. Verfasst von Liangzhi Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shandong University of Traditional Chinese Medicine, Shandong, 250002, People's Republic of China. Hauptthemen laut MEDLINE: Acute Lung Injury, Respiratory Distress Syndrome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Sailing Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute respiratory distress syndrome (ARDS) is a devastating respiratory disorder, characterized by overwhelming inflammation in the alveoli without effective pharmacological treatment. We aimed to investigate the effect and mechanism of angiotensin II type 2 receptor (AT2R) agonist, Compound 21 (C21), on the lipopolysaccharide (LPS)-induced acute lung injury (ALI) model. The protective effect of C21 was evaluated via enzyme-linked immunosorbent assay (ELISA), Western blot (WB), real-time PCR, and fluorescence microscopy in LPS-challenged THP1-derived macrophages. Besides, the in vivo efficacy of C21 was assessed using cell counting, ELISA, protein quantification, hematoxylin-eosin (H&E) staining, and WB in an LPS-induced ALI mouse model. The results showed that C21 significantly inhibited the secretion of pro-inflammatory cytokines (CCL-2, IL-6), overproduction of intracellular ROS, and activation of inflammatory pathways (NF-κB/NLRP3, p38/MAPK) in THP-1 cell-derived macrophages stimulated by LPS. In in vivo study, intraperitoneal injection of C21 could reduce airway leukocytes accumulation and chemokine/cytokine (keratinocyte chemoattractant (KC), IL-6) generation, as well as alleviate diffuse alveolar damage induced by LPS. Conclusively, the AT2R agonist C21 significantly inhibited LPS-stimulated excess inflammatory responses and oxidative stress in macrophages. Meanwhile, C21 could effectively alleviate acute inflammation and tissue damage in the lungs of ALI mice challenged by LPS. The results of this study bring new hope for the early treatment of ALI/ARDS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryRespiratory Distress SyndromeMiceAnimalsLipopolysaccharidesReceptor, Angiotensin, Type 2Interleukin-6CytokinesLungMacrophagesNF-kappa BInflammationImidazolesSulfonamidesThiophenes

Stichwörter der Autor:innen

Acute lung injuryAngiotensin II type2 receptor agonistC21InflammationMacrophage

Substanzen

LipopolysaccharidesReceptor, Angiotensin, Type 2Interleukin-6CytokinesNF-kappa Bcompound 21ImidazolesSulfonamidesThiophenes

Autor:innen und Institutionen

  • Shandong University of Traditional Chinese Medicine, Shandong, 250002, People's Republic of China.
  • Department of Clinical Laboratory, The Second Hospital, Cheeloo College of Medicine Shandong University, Shandong, 250033, People's Republic of China.
  • Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200120, People's Republic of China.
  • Department of Pulmonary and Critical Care Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, People's Republic of China.
  • Department of Pulmonary and Critical Care Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, People's Republic of China. 20310168@tongji.edu.cn.
  • Shandong University of Traditional Chinese Medicine, Shandong, 250002, People's Republic of China. lzlqhlz@163.com.

Förderung

  • National Natural Science Foundation of China
  • Shanghai Sailing Program

Zitieren

APA

Chen, L., Gong, P., Su, Y., Meng, L., Wang, M., Gao, W., & Liu, Q. (2024). Angiotensin II type 2 receptor agonist attenuates LPS-induced acute lung injury through modulating THP-1-derived macrophage reprogramming. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-023-02589-0

Vancouver

Chen L, Gong P, Su Y, Meng L, Wang M, Gao W, et al. Angiotensin II type 2 receptor agonist attenuates LPS-induced acute lung injury through modulating THP-1-derived macrophage reprogramming. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024. doi:10.1007/s00210-023-02589-0

BibTeX
@article{Chen2024,
  author = {Chen, Liangzhi and Gong, Ping and Su, Yue and Meng, Linlin and Wang, Muyun and Gao, Wei and Liu, Qinghua},
  title = {Angiotensin II type 2 receptor agonist attenuates LPS-induced acute lung injury through modulating THP-1-derived macrophage reprogramming},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2024},
  doi = {10.1007/s00210-023-02589-0}
}
Kostenlos starten →